Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir used primarily in the treatment of chronic hepatitis B infection. To support the analytical requirements… Read more



![Chemical structure of N-[(R)-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-L-alanine 1-Methylethyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F383365-04-6-N-R-1R-2-6-Amino-9H-purin-9-yl-1-methylethoxymethylphenoxyphosphinyl-L-alanine-1-Methylethyl-Ester.png&w=3840&q=75)
![Chemical structure of N-[[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]hydroxyphosphinyl]-D-alanine 1-Methylethyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F376633-26-0-N-1R-2-6-Amino-9H-purin-9-yl-1-methylethoxymethylhydroxyphosphinyl-D-alanine-1-Methylethyl-Ester.png&w=3840&q=75)







Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir used primarily in the treatment of chronic hepatitis B infection. To support the analytical requirements of pharmaceutical manufacturing and research, this category provides a comprehensive selection of reference standards, including identified impurities, degradation products, and metabolites. These compounds are essential for laboratories engaged in rigorous quality control, providing the necessary materials for method development and validation. Chemists utilize these reference materials for precise impurity profiling and to support forced degradation studies, ensuring consistency across manufacturing processes. Additionally, the inclusion of stable isotope labelled compounds facilitates accurate quantification and the tracking of metabolic pathways during bioanalytical studies. By using these qualified materials, laboratories can effectively meet regulatory standards and maintain the highest levels of accuracy in pharmaceutical testing and batch release protocols.